Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sorrento Therapeutics Company Profile (NASDAQ:SRNE)

Consensus Ratings for Sorrento Therapeutics (NASDAQ:SRNE) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.17 (67.26% upside)

Analysts' Ratings History for Sorrento Therapeutics (NASDAQ:SRNE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/19/2014HC WainrightSet Price TargetBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2014MLV & Co Reiterated RatingBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
12/15/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
10/2/2014HC WainrightInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014ZacksReiterated RatingOutperform -> Outperform$22.50ViewTweet This Rating  Share This Rating on StockTwits
6/18/2014MLV & Co Initiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2013Capital Ideas ResearchInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/3/2013AegisInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
11/20/2013CRT CapitalInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/22/2012 forward)